Dorota Nieoczym

Akademicka Str. 19
Lublin, LU 20033, Poland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Studies on the anticonvulsant potential of 6-gingerol, an active ingredient of ginger rhizome.

Studies on the anticonvulsant potential of 6-gingerol, an active ingredient of ginger rhizome.

Journal: Frontiers in pharmacology

Published: November 05, 2025

Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates.

Discovery and Profiling of New Multimodal Phenylglycinamide Derivatives as Potent Antiseizure and Antinociceptive Drug Candidates.

Journal: ACS chemical neuroscience

Published: August 21, 2024

Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization.

Novel Alaninamide Derivatives with Drug-like Potential for Development as Antiseizure and Antinociceptive Therapies─In Vitro and In Vivo Characterization.

Journal: ACS chemical neuroscience

Published: May 14, 2024

A comprehensive assessment of palmatine as anticonvulsant agent - In vivo and in silico studies.

A comprehensive assessment of palmatine as anticonvulsant agent - In vivo and in silico studies.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: November 08, 2023

In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice.

In Silico Analysis, Anticonvulsant Activity, and Toxicity Evaluation of Schisandrin B in Zebrafish Larvae and Mice.

Journal: International journal of molecular sciences

Published: July 23, 2023

Zebrafish as a robust preclinical platform for screening plant-derived drugs with anticonvulsant properties-a review.

Zebrafish as a robust preclinical platform for screening plant-derived drugs with anticonvulsant properties-a review.

Journal: Frontiers in molecular neuroscience

Published: May 12, 2023

Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment.

Anticonvulsant Profile of Selected Medium-Chain Fatty Acids (MCFAs) Co-Administered with Metformin in Mice in Acute and Chronic Treatment.

Journal: Molecules (Basel, Switzerland)

Published: February 27, 2023

Dietary Zinc Differentially Regulates the Effects of the GPR39 Receptor Agonist, TC-G 1008, in the Maximal Electroshock Seizure Test and Pentylenetetrazole-Kindling Model of Epilepsy.

Dietary Zinc Differentially Regulates the Effects of the GPR39 Receptor Agonist, TC-G 1008, in the Maximal Electroshock Seizure Test and Pentylenetetrazole-Kindling Model of Epilepsy.

Journal: Cells

Published: November 13, 2022

TC-G 1008 facilitates epileptogenesis by acting selectively at the GPR39 receptor but non-selectively activates CREB in the hippocampus of pentylenetetrazole-kindled mice.

TC-G 1008 facilitates epileptogenesis by acting selectively at the GPR39 receptor but non-selectively activates CREB in the hippocampus of pentylenetetrazole-kindled mice.

Journal: Cellular and molecular life sciences : CMLS

Published: October 03, 2022

Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo.

Discovery of (R)-N-Benzyl-2-(2,5-dioxopyrrolidin-1-yl)propanamide [(R)-AS-1], a Novel Orally Bioavailable EAAT2 Modulator with Drug-like Properties and Potent Antiseizure Activity In Vivo.

Journal: Journal of medicinal chemistry

Published: August 19, 2022

Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy-The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene.

Alterations of Serum Magnesium Concentration in Animal Models of Seizures and Epilepsy-The Effects of Treatment with a GPR39 Agonist and Knockout of the Gpr39 Gene.

Journal: Cells

Published: May 23, 2022

New Phenylglycinamide Derivatives with Hybrid Structure as Candidates for New Broad-Spectrum Anticonvulsants.

New Phenylglycinamide Derivatives with Hybrid Structure as Candidates for New Broad-Spectrum Anticonvulsants.

Journal: Cells

Published: May 18, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026